| Schedule of Changes in Stockholders’ Equity |
The
following are changes in stockholders’ equity for the three months ended March 31, 2025 and 2026:
Schedule of Changes in Stockholders’ Equity
| | |
| | |
| | |
Additional | | |
| | |
| |
| | |
Common Stock | | |
paid in | | |
Accumulated | | |
| |
| | |
Shares | | |
Amount | | |
Capital | | |
(Deficit) | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| |
| Balance December 31, 2024 | |
| 14,746,172 | | |
$ | - | | |
$ | 64,199,000 | | |
$ | (63,621,000 | ) | |
$ | 578,000 | |
| Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding | |
| 121,082 | | |
| - | | |
| (160,000 | ) | |
| - | | |
| (160,000 | ) |
| Shares issued in settlement of former Arps shareholder and manager notes | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Issuance of detachable warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Equity-based compensation expense | |
| - | | |
| - | | |
| 158,000 | | |
| - | | |
| 158,000 | |
| Registered issuance of common stock | |
| 1,052,793 | | |
| - | | |
| 2,974,000 | | |
| - | | |
| 2,974,000 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| (761,000 | ) | |
| (761,000 | ) |
| Balance March 31, 2025 | |
| 15,920,047 | | |
$ | - | | |
$ | 67,171,000 | | |
$ | (64,382,000 | ) | |
$ | 2,789,000 | |
| | |
| | |
| | |
Additional | | |
| | |
| |
| | |
Common Stock | | |
paid in | | |
Accumulated | | |
| |
| | |
Shares | | |
Amount | | |
Capital | | |
(Deficit) | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| |
| Balance December 31, 2025 | |
| 15,969,281 | | |
$ | - | | |
$ | 67,645,000 | | |
$ | (66,315,000 | ) | |
$ | 1,330,000 | |
| Balance | |
| 15,969,281 | | |
$ | - | | |
$ | 67,645,000 | | |
$ | (66,315,000 | ) | |
$ | 1,330,000 | |
| Equity-based compensation expense | |
| - | | |
| - | | |
| 102,000 | | |
| - | | |
| 102,000 | |
| Shares issued in settlement of former Arps shareholder and manager notes | |
| 135,572 | | |
| - | | |
| 420,000 | | |
| - | | |
| 420,000 | |
| Issuance of detachable warrants | |
| - | | |
| - | | |
| 487,000 | | |
| | | |
| 487,000 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| (661,000 | ) | |
| (661,000 | ) |
| Balance March 31, 2026 | |
| 16,104,853 | | |
$ | - | | |
$ | 68,654,000 | | |
$ | (66,976,000 | ) | |
$ | 1,678,000 | |
| Balance | |
| 16,104,853 | | |
$ | - | | |
$ | 68,654,000 | | |
$ | (66,976,000 | ) | |
$ | 1,678,000 | |
|
| Schedule of Stock Options Activity |
The
following is a summary of stock option activity for the three months ended March 31, 2026:
Schedule of Stock Options Activity
| | |
Number of
Options | | |
Weighted average
exercise price
per share | | |
Remaining
term in years | |
| Outstanding on December 31, 2025 | |
| 763,002 | | |
$ | 4.60 | | |
| 5.3 | |
| Granted | |
| 1,923 | | |
$ | 2.81 | | |
| 8.0 | |
| Forfeited | |
| (22,831 | ) | |
$ | 2.53 | | |
| | |
| Outstanding on March 31, 2026 | |
| 742,094 | | |
$ | 4.66 | | |
| 4.9 | |
| | |
| | | |
| | | |
| | |
| Exercisable, March 31, 2026 | |
| 538,842 | | |
$ | 5.39 | | |
| 3.6 | |
|